Clicky

CVRx, Inc.(CVRX)

Description: CVRx, Inc. develops an implantable technology for the treatment of high blood pressure/hypertension and heart failure patients. It offers BAROSTIM NEO, a neuro-modulation therapy that triggers the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure, which is delivered through a long-lasting implant system, and customized to each patient's individual therapy needs. The company serves patients and healthcare professionals. CVRx, Inc. was incorporated in 2000 and is based in Minneapolis, Minnesota. It has operations in the United States, the United Kingdom, the Netherlands, Italy, Germany, and internationally.


Keywords: Medical Device Hypertension Heart Failure Heart Blood Pressure Organ Failure Organs Anatomy) Treatment Of High Blood Pressure

Home Page: www.cvrx.com

CVRX Technical Analysis

9201 West Broadway Avenue
Minneapolis, MN 55445
United States
Phone: 763 416 2840


Officers

Name Title
Mr. Nadim Yared CEO, Pres & Director
Mr. Jared Oasheim Chief Financial Officer
Mr. Paul Verrastro Chief Marketing & Strategy Officer
Mr. Paul Pignato VP of Operations
Mr. Craig Palmer Sr. VP of US Sales

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0.2414
Price-to-Book MRQ: 2.4006
Price-to-Sales TTM: 16.2167
IPO Date: 2021-06-30
Fiscal Year End: December
Full Time Employees: 109
Back to stocks